MolecuLight Inc.: FDA 510(k) Clearance Expands Labelling of MolecuLight i:X to Include the Ability to Identify Regions Containing Elevated Load and More Bacterial Species

New FDA Clearance Illustrates the Utility of the i:X to Reliably DetectClinically Significant Bacteria that Impedes Wound Healing TORONTO, June 29, 2022 /PRNewswire/ -- MolecuLight Inc.

Related Keywords

United States ,Toronto ,Ontario ,Canada ,Kostenloser Wertpapierhandel ,Rob Sandler ,Rose Raizman ,Human Services ,Surgical Center ,Us Department Of Health ,Moleculight Inc ,Prnewswire Moleculight Inc ,Hospital Outpatient Department ,Significant Bacteria ,Impedes Wound ,Light Inc ,Anil Amlani ,Resistance Threats ,Ambulatory Surgical Center ,Ambulatory Payment Classification ,Chief Marketing Officer ,Moleculight ,Clearance ,Xpands ,Labelling ,Nclude ,Ability ,Identify ,Regions ,Containing ,Levated ,Road ,More ,Bacterial ,Species ,